Delivery Order SPE2DB25D3012-SPE2DB25FWZHF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,270.22 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.53 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pharmaceutical products. This firm fixed price delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order, this award falls...
- The Defense Logistics Agency awarded a $27,040.46 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $9,080.88 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA...
- The Defense Logistics Agency awarded a $13,348.64 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 2, 2025. This competitive, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The order will be fulfilled from the vendor's corporate office...
- The Defense Logistics Agency awarded a $2,727.69 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance at the contractor's Conshohocken, Pennsylvania facility. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 2, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $9,272.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $27,880.54 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 5, 2025. This non-competitive delivery order represents a firm fixed-price purchase under the company's existing contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,783.70 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector medication, with an ultimate completion date of August 22, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. This...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZHFDelivery Order
The Defense Logistics Agency awarded a $2,318.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 19, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's expansive relationship with the Defense Logistics Agency. The company maintains a significant Indefinite Delivery Contract valued at $999,999,999 with DLA Troop Support Medical through December 2026, which serves as the strategic vehicle supporting military healthcare systems globally. AmerisourceBergen's role as a Prime Vendor for pharmaceutical products and medical supplies enables it to fulfill critical medical procurement needs for the Defense Health Agency and other federal healthcare systems. The Repatha order, a branded PCSK9 inhibitor used in cardiovascular treatment, exemplifies the specialized pharmaceutical commodities the company regularly delivers to support military medical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/18/25 |